Worldwide Mitochondrial-based Therapeutics Market Research Report 2021 by Type, Application, Participants and Countries, Forecast Year to 2026
- PRO4354908
- 115 Pages
- March 2021
- Healthcare
Mitochondria existing in human cell is in charge of creating 90% of power in body. illness triggered by mutations of mitochondrial dna are dealt with making use of mitochondrial-based rehabs.
Mitochondrial disorder contributes lots of conditions like neurodegeneration, cardiac arrest, metabolic illness or ischemic-reperfusion injury. mitochondrial-based rehabs consists of mitochondria as a medication target for treatment of chronic, genetic and progressive illness.
Mitochondrial disorder has signs like poor development, muscle weakness, finding out handicaps, boosted danger of infection, respiratory issue as well as a lot more. according to the nationwide institute of health and wellness (nih), mitochondrial conditions is most usual kind of hereditary illness with minimal prevalence of above 1 in 5000 people around the world.
Covid-19 has actually led to a change of focus for several biopharmaceutical companies to discover coronavirus remedy, postponing study as well as growth tasks in mitochondrial-based therapeutics market.
Producing tasks have actually been placed on stop across numerous unit as a result of close down leading lowered development price of mitochondrial-based rehabs market. decrease in medical diagnosis and also treatment adoption rate owing to reduced patient visits to medical care facilities is influencing mitochondrial-based rehabs market.
Surge in occurrence of mitochondrial conditions is anticipated to enhance need for mitochondrial-based therapeutics market. raising collective study as well as growth activities amongst leading biopharmaceutical ingenious players is expected to fuel the development of mitochondrial-based therapeutics market.
For instance in june 2020 reneo drugs leading medication candidate ren001 was provided orphan drug classification by the U.S. food and also medicines administration for treatment of main mitochondrial myopathy.
On top of that clinical-stage growth business are designating considerable funds towards the advancement of mitochondrial-based therapeutics market. as an example in october 2019 alexion pharmaceuticals and stealth biotherapeutics corp. revealed their partnership to co-develop and commercialize elamipretide medication made use of as restorative for mitochondrial disorder.
Lack of recognition concerning therapeutic options readily available for mitochondrial dysfunction is anticipated to hinder mitochondrial-based therapeutics market growth. rigorous regulative need for medication authorization are challenging mitochondrial-based therapies market growth.
Nsaids is anticipated to hold major income share of mitochondrial-based therapeutics market during projection duration. mitochondrial myopathy created biggest income share for mitochondrial-based therapeutics market. lebers heredity optic neuropathy as well as leigh disorder are anticipated to produce substantial income in mitochondrial-based rehabs market.
Dental medications are most generally used in mitochondrial-based therapies market. whereas medical facility drug stores is a biggest circulation network for mitochondrial-based rehabs market. on the internet pharmacies is anticipated to observe significant development price in coming years with increased price of fostering.
The United States and Canada will certainly continue to control the mitochondrial-based therapies market in the coming decade with a high price of approvals as well as commercialization of pharmaceutical medicines. the high rate of occurrence of mitochondrial dysfunctions enhances the demand for mitochondrial-based therapeutics market in north America.
Europe is the 2nd prominent region in mitochondrial-based rehabs market with enhanced financial investments in the direction of research study as well as development activities. Asia-pacific is lucrative with a greater development price in mitochondrial-based rehabs market throughout the projection period with a large individual population in the region.
The middle east and Africa are anticipated to observe the least development in mitochondrial-based therapies market due to less medical care expense in the region.
Some principals contributing in mitochondrial-based rehabs market are
Pfizer inc.
Norvartis ag
Takeda drugs
Amgen inc.
Neurovive pharmaceutical ab
Entogene ag
Stealth biotherapeutics
Ixchel pharma
Reata drugs
Khondrion bv
Alkeus drugs
Obstruct medications
The report on mitochondrial-based therapies market covers extensive analysis on:
Market sectors
Market characteristics
Historical actual market dimension 2015 - 2019
Market dimension & projection 2020 to 2030
Supply & need value chain
Market existing trends/issues/challenges
Competitors & firms involved
Technology
Worth chain
Market vehicle drivers as well as restraints
Regional analysis for mitochondrial-based therapeutics market consists of
North America
Latin America
Europe
East Asia
South Asia
Oceania
Center eastern & Africa
Record on mitochondrial-based therapies market highlights:
Moving sector characteristics
In-depth market division
Historic current and also projected market size
Current industry fads
Key competition landscape
Strategies of crucial players and also product offerings
Possible and also particular niche segments/regions displaying promising growth
A neutral viewpoint towards market performance
Mitochondrial-based therapeutics market: segmentation
The global mitochondrial-based rehabs market is identified based on medicine kind, indicator, route of administration, circulation channel as well as region.
Medicine type
Anti-inflammatory biologics
Non-steroidal anti-inflammatory medicines (nsaids)
Corticosteroids
Indicator
Mitochondrial myopathy
Lebers heredity optic neuropathy
Leigh syndrome
Mitochondrial dna depletion disorder
Mitochondrial encephalomyopathy
Lactic acidosis
Myoclonic epilepsy with rough red fibres
Route of management
Oral
Intravenous
Distribution network
Hospital drug stores
Retail pharmacies
Drug shops
On-line drug stores
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Volume Units
1.8 Review Cycle
1.9 Summary and Key Findings of the Research
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach (Involves time, Space, and Persons)
2.3 Data Triangulation
2.4 Assumptions
2.5 Hypothesis of this Research, Clear, specific, and testable statement of this research
2.6 Limitations of Our Study
2.7 Scene Based Modeling
2.8 Covid-19 Impact/Evaluation
3. Market Dynamics
3.1 Driving Factors
3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
3.1.2 Increasing Use of Mitochondrial-based Therapeutics by Different End-User/Applications
3.2 Restraints and Challenges in the Market
3.3 Opportunities
4. Global Mitochondrial-based Therapeutics Market-Segmentation
4.1 By Type
…
4.2 By End-User/Application Industry
…
4.3 By Geography
4.3.1 North America Mitochondrial-based Therapeutics Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.1.1 North America Mitochondrial-based Therapeutics Production from 2014-2020
4.3.1.2 North America Mitochondrial-based Therapeutics Consumption from 2014-2020
4.3.1.3 North America Mitochondrial-based Therapeutics Import and Export from 2014-2020
4.3.1.4 North America Mitochondrial-based Therapeutics Market Value ($) and Growth (%) by Type from 2019-2020
4.3.1.5 North America Mitochondrial-based Therapeutics Market Value ($) and Growth (%) by Application from 2019-2020
4.3.1.6 North America Mitochondrial-based Therapeutics Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.1.7 Top North America Mitochondrial-based Therapeutics Participants Value ($) and Market Share (%) in 2020
4.3.2 Europe Mitochondrial-based Therapeutics Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.2.1 Europe Mitochondrial-based Therapeutics Production from 2014-2020
4.3.2.2 Europe Mitochondrial-based Therapeutics Consumption from 2014-2020
4.3.2.3 Europe Mitochondrial-based Therapeutics Import and Export from 2014-2020
4.3.2.4 Europe Mitochondrial-based Therapeutics Market Value ($) and Growth (%) by Type from 2019-2020
4.3.2.5 Europe Mitochondrial-based Therapeutics Value ($) and Growth (%) by Application from 2019-2020
4.3.2.6 Europe Mitochondrial-based Therapeutics Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.2.7 Top Europe Mitochondrial-based Therapeutics Participants Value ($) and Market Share (%) in 2020
4.3.3 Asia-Pacific Mitochondrial-based Therapeutics Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.3.1 Asia-Pacific Mitochondrial-based Therapeutics Production from 2014-2020
4.3.3.2 Asia-Pacific Mitochondrial-based Therapeutics Consumption from 2014-2020
4.3.3.3 Asia-Pacific Mitochondrial-based Therapeutics Import and Export from 2014-2020
4.3.3.4 Asia-Pacific Mitochondrial-based Therapeutics Value ($) and Growth (%) by Type from 2019-2020
4.3.3.5 Asia-Pacific Mitochondrial-based Therapeutics Value ($) and Growth (%) by Application from 2019-2020
4.3.3.6 Asia-Pacific Mitochondrial-based Therapeutics Value ($) and Growth (%) by Countries from 2019-2020
4.3.3.7 Top Asia-Pacific Mitochondrial-based Therapeutics Participants Value ($) and Market Share (%) in 2020
4.3.4 Latin America Mitochondrial-based Therapeutics Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.4.1 Latin America Mitochondrial-based Therapeutics Production from 2014-2020
4.3.4.2 Latin America Mitochondrial-based Therapeutics Consumption from 2014-2020
4.3.4.3 Latin America Mitochondrial-based Therapeutics Import and Export from 2014-2020
4.3.4.4 Latin America Mitochondrial-based Therapeutics Value ($) and Growth (%) by Type from 2019-2020
4.3.4.5 Latin America Mitochondrial-based Therapeutics Value ($) and Growth (%) by Application from 2019-2020
4.3.4.6 Latin America Mitochondrial-based Therapeutics Value ($) and Growth (%) by Countries from 2019-2020
4.3.4.7 Top Latin America Mitochondrial-based Therapeutics Participants Value ($) and Market Share (%) in 2020
4.3.5 Middle East & Africa Mitochondrial-based Therapeutics Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.5.1 Middle East & Africa Mitochondrial-based Therapeutics Production from 2014-2020
4.3.5.2 Middle East & Africa Mitochondrial-based Therapeutics Consumption from 2014-2020
4.3.5.3 Middle East & Africa Mitochondrial-based Therapeutics Import and Export from 2014-2020
4.3.5.4 Middle East & Africa Mitochondrial-based Therapeutics Value ($) and Growth (%) by Type from 2019-2020
4.3.5.5 Middle East & Africa Mitochondrial-based Therapeutics Value ($) and Growth (%) by Application from 2019-2020
4.3.5.6 Middle East & Africa Mitochondrial-based Therapeutics Value ($) and Growth (%) by Countries from 2019-2020
4.3.5.7 Top Middle East & Africa Mitochondrial-based Therapeutics Participants Value ($) and Market Share (%) in 2020
5. Global Level Competitive Intelligence – Company Profiles
5.1 Company one
5.1.1 Company one Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.1.2 Company one Sales, Growth Rate and Global Market Share from 2014-2020
5.2 Company two
5.2.1 Company two Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.2.2 Company two Sales, Growth Rate and Global Market Share from 2014-2020
5.3 Company three
5.3.1 Company three Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.3.2 Company three Sales, Growth Rate and Global Market Share from 2014-2020
5.4 Company four
5.4.1 Company four Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.4.2 Company four Sales, Growth Rate and Global Market Share from 2014-2020
5.5 Company five
5.5.1 Company five Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.5.2 Company five Sales, Growth Rate and Global Market Share from 2014-2020
5.6 Company six
5.6.1 Company six Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.6.2 Company six Sales, Growth Rate and Global Market Share from 2014-2020
5.7 Company seven
5.7.1 Company seven Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.7.2 Company seven Sales, Growth Rate and Global Market Share from 2014-2020
5.8 Company eight
5.8.1 Company eight Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.8.2 Company eight Sales, Growth Rate and Global Market Share from 2014-2020
5.9 Company nine
5.9.1 Company nine Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.9.2 Company nine Sales, Growth Rate and Global Market Share from 2014-2020
5.10 Company ten
5.10.1 Company ten Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.10.2 Company ten Sales, Growth Rate and Global Market Share from 2014-2020
5.11 Company 11
5.11.1 Company 11 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.11.2 Company 11 Sales, Growth Rate and Global Market Share from 2014-2020
5.12 Company 12
5.12.1 Company 12 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.12.2 Company 12 Sales, Growth Rate and Global Market Share from 2014-2020
5.13 Company 13
5.13.1 Company 13 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.13.2 Company 13 Sales, Growth Rate and Global Market Share from 2014-2020
5.14 Company 14
5.14.1 Company 14 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.14.2 Company 14 Sales, Growth Rate and Global Market Share from 2014-2020
5.15 Company 15
5.15.1 Company 15 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.15.2 Company 15 Sales, Growth Rate and Global Market Share from 2014-2020
...
6. Investment Analysis
6.1 Fundamental Analysis (Porter's Five Forces Analysis)
6.2 Technical Preparation Analysis
6.3 Risk Evaluating Analysis
6.4 Estimated Investment Pay-Back Period
7. Future Forecast of Global Mitochondrial-based Therapeutics Market from 2020-2026
7.1 Future Forecast of Global Mitochondrial-based Therapeutics Market from 2020-2026 Segment by Regions
7.2 Future Forecast of Global Mitochondrial-based Therapeutics Market from 2020-2026 Segment by Type
7.3 Future Forecast of Global Mitochondrial-based Therapeutics Market from 2020-2026 Segment by Application
8 Appendix
8.1 Discussion Guide
8.2 Related Reports
8.3 Author List
421 Disclaimer
Table Key Data from Secondary Sources
Table Key Data Parameter
Figure Market Size Estimation by End-Use Industry
Figure Market: Data Triangulation
Figure Market Size Estimation: Top-Down Approach
Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)
Table Global Mitochondrial-based Therapeutics Production and Growth Rate Segment by Product Types from 2014-2020
Table Global Mitochondrial-based Therapeutics Value ($) and Growth Rate Segment by Product Types from 2014-2020
Figure Type 1 of Mitochondrial-based Therapeutics
Figure Type 2 of Mitochondrial-based Therapeutics
Figure Type 3 of Mitochondrial-based Therapeutics
Table Global Mitochondrial-based Therapeutics Consumption and Growth Rate Segment by End-User/Application from 2014-2020
Table Global Mitochondrial-based Therapeutics Value ($) and Growth Rate Segment by End-User/Application from 2014-2020
Figure Application 1 of Mitochondrial-based Therapeutics
Figure Application 2 of Mitochondrial-based Therapeutics
Figure Application 3 of Mitochondrial-based Therapeutics
Table Global Mitochondrial-based Therapeutics Production Value ($) by Regions
Table Global Mitochondrial-based Therapeutics Production Value Share by Regions
Table Global Mitochondrial-based Therapeutics Production by Regions
Table Global Mitochondrial-based Therapeutics Production Share by Regions
Table Global Mitochondrial-based Therapeutics Consumption by Regions
Table Global Mitochondrial-based Therapeutics Consumption Share by Regions
Figure North America Mitochondrial-based Therapeutics Production and Growth Rate from 2014-2020
Figure North America Mitochondrial-based Therapeutics Consumption and Growth Rate from 2014-2020
Table North America Mitochondrial-based Therapeutics Import and Export from 2014-2020
Table North America Mitochondrial-based Therapeutics Value ($) and Growth (%) by Type from 2019-2020
Table North America Mitochondrial-based Therapeutics Value ($) and Growth (%) by Application from 2019-2020
Table North America Mitochondrial-based Therapeutics Value ($) and Growth (%) by Countries from 2019-2020
Table Top North America Mitochondrial-based Therapeutics Participants Value ($) and Market Share (%) in 2020
Figure Europe Mitochondrial-based Therapeutics Production and Growth Rate from 2014-2020
Figure Europe Mitochondrial-based Therapeutics Consumption and Growth Rate from 2014-2020
Table Europe Mitochondrial-based Therapeutics Import and Export from 2014-2020
Table Europe Mitochondrial-based Therapeutics Value ($) and Growth (%) by Type from 2019-2020
Table Europe Mitochondrial-based Therapeutics Value ($) and Growth (%) by Application from 2019-2020
Table Europe Mitochondrial-based Therapeutics Market Value ($) and Growth (%) by Countries from 2019-2020
Table Top Europe Mitochondrial-based Therapeutics Participants Value ($) and Market Share (%) in 2020
Figure Asia-Pacific Mitochondrial-based Therapeutics Production and Growth Rate from 2014-2020
Figure Asia-Pacific Mitochondrial-based Therapeutics Consumption and Growth Rate from 2014-2020
Table Asia-Pacific Mitochondrial-based Therapeutics Import and Export from 2014-2020
Table Asia-Pacific Mitochondrial-based Therapeutics Value ($) and Growth (%) by Type from 2019-2020
Table Asia-Pacific Mitochondrial-based Therapeutics Value ($) and Growth (%) by Application from 2019-2020
Table Asia-Pacific Mitochondrial-based Therapeutics Value ($) and Growth (%) by Countries from 2019-2020
Table Top Asia-Pacific Mitochondrial-based Therapeutics Participants Value ($) and Market Share (%) in 2020
Figure Latin America Mitochondrial-based Therapeutics Production and Growth Rate from 2014-2020
Figure Latin America Mitochondrial-based Therapeutics Consumption and Growth Rate from 2014-2020
Table Latin America Mitochondrial-based Therapeutics Import and Export from 2014-2020
Table Latin America Mitochondrial-based Therapeutics Value ($) and Growth (%) by Type from 2019-2020
Table Latin America Mitochondrial-based Therapeutics Value ($) and Growth (%) by Application from 2019-2020
Table Latin America Mitochondrial-based Therapeutics Value ($) and Growth (%) by Countries from 2019-2020
Table Top Latin America Mitochondrial-based Therapeutics Participants Value ($) and Market Share (%) in 2020
Figure Middle East & Africa Mitochondrial-based Therapeutics Production and Growth Rate from 2014-2020
Figure Middle East & Africa Mitochondrial-based Therapeutics Consumption and Growth Rate from 2014-2020
Table Middle East & Africa Mitochondrial-based Therapeutics Import and Export from 2014-2020
Table Middle East & Africa Mitochondrial-based Therapeutics Value ($) and Growth (%) by Type from 2019-2020
Table Middle East & Africa Mitochondrial-based Therapeutics Value ($) and Growth (%) by Application from 2019-2020
Table Middle East & Africa Mitochondrial-based Therapeutics Value ($) and Growth (%) by Countries from 2019-2020
Table Top Middle East & Africa Mitochondrial-based Therapeutics Participants Value ($) and Market Share (%) in 2020
Table Company one Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company one Sales and Growth Rate from 2014-2020
Figure Company one Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company two Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company two Sales and Growth Rate from 2014-2020
Figure Company two Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company three Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company three Sales and Growth Rate from 2014-2020
Figure Company three Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company four Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company four Sales and Growth Rate from 2014-2020
Figure Company four Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company five Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company five Sales and Growth Rate from 2014-2020
Figure Company five Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company six Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company six Sales and Growth Rate from 2014-2020
Figure Company six Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company seven Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company seven Sales and Growth Rate from 2014-2020
Figure Company seven Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company eight Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company eight Sales and Growth Rate from 2014-2020
Figure Company eight Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company nine Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company nine Sales and Growth Rate from 2014-2020
Figure Company nine Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company ten Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company ten Sales and Growth Rate from 2014-2020
Figure Company ten Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 11 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 11 Sales and Growth Rate from 2014-2020
Figure Company 11 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 12 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 12 Sales and Growth Rate from 2014-2020
Figure Company 12 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 13 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 13 Sales and Growth Rate from 2014-2020
Figure Company 13 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 14 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 14 Sales and Growth Rate from 2014-2020
Figure Company 14 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 15 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 15 Sales and Growth Rate from 2014-2020
Figure Company 15 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Global Mitochondrial-based Therapeutics Value ($) and Growth Rate Forecast by Regions (2020-2026)
Table Global Mitochondrial-based Therapeutics Production and Growth Rate Forecast by Regions (2020-2026)
Table Global Mitochondrial-based Therapeutics Consumption and Growth Rate Forecast by Regions (2020-2026)
Table Global Mitochondrial-based Therapeutics Production and Growth Rate Forecast by Types (2020-2026)
Table Global Mitochondrial-based Therapeutics Consumption and Growth Rate Forecast by End-User/Applications (2020-2438)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
